According to exploratory model-based analyses of most recent clinical data, ISA placement can be expected to meaningfully delay the need for TKA in symptomatic patients with medial knee OA, resulting in improved patient quality of life that appears to render ISA a cost-effective, high value intervention across a wide range of tested assumptions.
